Canopy Growth Corp (TSE:WEED – Get Free Report)’s share price reached a new 52-week low during trading on Friday. The stock traded as low as C$0.83 and last traded at C$0.87, with a volume of 1,411,513 shares trading hands. The stock had previously closed at C$0.95.
Canopy Growth Stock Down 8.4%
The stock has a market capitalization of C$368.04 million, a price-to-earnings ratio of -1.30, a price-to-earnings-growth ratio of -0.01 and a beta of 2.07. The company has a quick ratio of 2.32, a current ratio of 3.04 and a debt-to-equity ratio of 40.27. The stock has a 50 day moving average price of C$1.19 and a 200 day moving average price of C$1.38.
Canopy Growth (TSE:WEED – Get Free Report) last released its quarterly earnings data on Friday, November 6th. The company reported C($0.10) earnings per share (EPS) for the quarter. Canopy Growth had a negative net margin of 73.95% and a negative return on equity of 29.85%. The firm had revenue of C$81.37 million during the quarter. As a group, analysts forecast that Canopy Growth Corp will post -0.69 EPS for the current year.
Insider Buying and Selling
In related news, Director David Angelo Lazzarato sold 22,380 shares of Canopy Growth stock in a transaction that occurred on Monday, September 28th. The shares were sold at an average price of C$1.29, for a total transaction of C$28,870.20. Following the sale, the director directly owned 108,237 shares in the company, valued at C$139,625.73. This trade represents a 17.13% decrease in their position. In the last 90 days, insiders have sold 43,492 shares of company stock worth $56,105. 0.21% of the stock is owned by company insiders.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Recommended Stories
- Five stocks we like better than Canopy Growth
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
- Block by Block: Cash App Builds a Stronger Foundation
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
